New Combo KOs HCV Without Interferon, Ribavirin (CME/CE)
(MedPage Today) — A combination of direct-acting antiviral agents aimed at hepatitis C — and given without standard therapy — can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com